Juan-Li Gu

3.4k total citations
29 papers, 3.0k citations indexed

About

Juan-Li Gu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Juan-Li Gu has authored 29 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Juan-Li Gu's work include Neuroscience and Neuropharmacology Research (5 papers), Cardiac Ischemia and Reperfusion (5 papers) and Antioxidant Activity and Oxidative Stress (5 papers). Juan-Li Gu is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Cardiac Ischemia and Reperfusion (5 papers) and Antioxidant Activity and Oxidative Stress (5 papers). Juan-Li Gu collaborates with scholars based in United States and United Kingdom. Juan-Li Gu's co-authors include Tianli Yue, Paul G. Lysko, G Feuerstein, Eliot H. Ohlstein, Patrick McKenna, Giora Feuerstein, Kathryn A. Lysko, Cheng Huan, Beverly E. Maleeff and Chuanlin Wang and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Circulation Research.

In The Last Decade

Juan-Li Gu

29 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juan-Li Gu United States 25 1.4k 933 492 428 316 29 3.0k
Mary O. Gray United States 21 1.8k 1.3× 880 0.9× 717 1.5× 432 1.0× 99 0.3× 25 2.9k
Hideharu Hayashi Japan 31 1.5k 1.1× 1.1k 1.2× 483 1.0× 542 1.3× 117 0.4× 142 3.0k
Takayuki Ito Japan 32 1.2k 0.9× 1.2k 1.3× 232 0.5× 637 1.5× 241 0.8× 104 3.3k
Xin L. United States 27 1.3k 1.0× 1.1k 1.2× 812 1.7× 1.0k 2.4× 294 0.9× 44 3.4k
David D. Ku United States 29 1.0k 0.7× 921 1.0× 386 0.8× 1.2k 2.8× 249 0.8× 68 3.3k
Che-Hong Chen United States 17 1.5k 1.1× 534 0.6× 838 1.7× 475 1.1× 119 0.4× 18 2.7k
Akiko Ogai Japan 22 963 0.7× 807 0.9× 453 0.9× 315 0.7× 157 0.5× 33 2.4k
Naoki Makino Japan 34 1.2k 0.8× 980 1.1× 271 0.6× 773 1.8× 226 0.7× 130 3.0k
Atsuo Goto Japan 35 1.8k 1.3× 964 1.0× 210 0.4× 760 1.8× 288 0.9× 124 4.2k
Carolyn J. Smith United States 31 1.8k 1.3× 989 1.1× 213 0.4× 1.3k 3.0× 188 0.6× 46 3.7k

Countries citing papers authored by Juan-Li Gu

Since Specialization
Citations

This map shows the geographic impact of Juan-Li Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan-Li Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan-Li Gu more than expected).

Fields of papers citing papers by Juan-Li Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan-Li Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan-Li Gu. The network helps show where Juan-Li Gu may publish in the future.

Co-authorship network of co-authors of Juan-Li Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Juan-Li Gu. A scholar is included among the top collaborators of Juan-Li Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan-Li Gu. Juan-Li Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yue, Tianli, Weike Bao, Beat M. Jucker, et al.. (2003). Activation of Peroxisome Proliferator–Activated Receptor-α Protects the Heart From Ischemia/Reperfusion Injury. Circulation. 108(19). 2393–2399. 165 indexed citations
3.
Lysko, Paul G., et al.. (2000). A Comparison of Carvedilol and Metoprolol Antioxidant Activities In Vitro. Journal of Cardiovascular Pharmacology. 36(2). 277–281. 54 indexed citations
4.
Yue, Tianli, Juan-Li Gu, Chuanlin Wang, et al.. (2000). Extracellular Signal-regulated Kinase Plays an Essential Role in Hypertrophic Agonists, Endothelin-1 and Phenylephrine-induced Cardiomyocyte Hypertrophy. Journal of Biological Chemistry. 275(48). 37895–37901. 167 indexed citations
5.
Gao, Feng, Jun Chen, Bernard L. Lopez, et al.. (2000). Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model. European Journal of Pharmacology. 406(1). 109–116. 40 indexed citations
6.
Yue, Tianli, Lynne M. Vickery‐Clark, Calvert Louden, et al.. (2000). Selective Estrogen Receptor Modulator Idoxifene Inhibits Smooth Muscle Cell Proliferation, Enhances Reendothelialization, and Inhibits Neointimal Formation In Vivo After Vascular Injury. Circulation. 102(Supplement 3). III–281. 28 indexed citations
8.
Yue, Tianli, Jian Ni, Anne M. Romanic, et al.. (1999). TL1, a Novel Tumor Necrosis Factor-like Cytokine, Induces Apoptosis in Endothelial Cells. Journal of Biological Chemistry. 274(3). 1479–1486. 95 indexed citations
9.
Yue, Tianli, Xinliang Ma, Juan-Li Gu, Robert Ruffolo, & Giora Feuerstein. (1998). Carvedilol inhibits activation of stress-activated protein kinase and reduces reperfusion injury in perfused rabbit heart. European Journal of Pharmacology. 345(1). 61–65. 31 indexed citations
11.
Wang, Xinkang, Calvert Louden, Eliot H. Ohlstein, et al.. (1996). Osteopontin Expression in Platelet-Derived Growth Factor–Stimulated Vascular Smooth Muscle Cells and Carotid Artery After Balloon Angioplasty. Arteriosclerosis Thrombosis and Vascular Biology. 16(11). 1365–1372. 56 indexed citations
12.
Yue, Tian-Li, Xiaolin Wang, Juan-Li Gu, Robert Ruffolo, & G Feuerstein. (1995). Carvedilol, a new vasodilating beta-adrenoceptor blocker, inhibits oxidation of low-density lipoproteins by vascular smooth muscle cells and prevents leukocyte adhesion to smooth muscle cells.. Journal of Pharmacology and Experimental Therapeutics. 273(3). 1442–1449. 56 indexed citations
14.
Yue, Tianli, Patrick McKenna, Paul G. Lysko, et al.. (1994). SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant. European Journal of Pharmacology. 251(2-3). 237–243. 63 indexed citations
15.
Feuerstein, G, Juan-Li Gu, Eliot H. Ohlstein, Frank C. Barone, & Tongpeng Yue. (1994). Peptidic endothelin-1 receptor antagonist, BQ-123, and neuroprotection. Peptides. 15(3). 467–469. 35 indexed citations
16.
Yue, Tianli, Frank C. Barone, Juan-Li Gu, & Giora Feuerstein. (1993). Brain α-tocopherol levels are not altered following ischemia/reperfusion-induced cerebral injury in rats and gerbils. Brain Research. 610(1). 53–56. 8 indexed citations
17.
Yue, Tianli, Patrick McKenna, Juan-Li Gu, & Giora Feuerstein. (1993). Interleukin-8 is chemotactic for vascular smooth muscle cells. European Journal of Pharmacology. 240(1). 81–84. 49 indexed citations
18.
Yue, Tianli, Juan-Li Gu, Paul G. Lysko, et al.. (1992). Neuroprotective effects of phenyl-t-butyl-nitrone in gerbil global brain ischemia and in cultured rat cerebellar neurons. Brain Research. 574(1-2). 193–197. 103 indexed citations
19.
Lysko, Paul G., Kathryn A. Lysko, Tingting Yue, et al.. (1992). Neuroprotective effects of carvedilol, a new antihypertensive agent, in cultured rat cerebellar neurons and in gerbil global brain ischemia.. Stroke. 23(11). 1630–1635. 69 indexed citations
20.
Yue, Tianli, Cheng Huan, Paul G. Lysko, et al.. (1992). Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.. Journal of Pharmacology and Experimental Therapeutics. 263(1). 92–98. 420 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026